PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

P Budde; J Marte; H-D Zucht; S Bhandari; M Tuschen; P Schulz-Knappe; J Gulley; C Heery; R Madan; J Schlom

doi:10.1136/lupus-2018-abstract.76

Article info

Poster session 2: Autoantibodies, biomarkers and imaging (2), Environmental, epigenetics and genomics

PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

Free

Authors

P Budde 1Protagen AG, Dortmund, Germany, Dortmund, Germany PubMed articles Google scholar articles
J Marte 2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA PubMed articles Google scholar articles
H-D Zucht 1Protagen AG, Dortmund, Germany, Dortmund, Germany PubMed articles Google scholar articles
S Bhandari 1Protagen AG, Dortmund, Germany, Dortmund, Germany PubMed articles Google scholar articles
M Tuschen 1Protagen AG, Dortmund, Germany, Dortmund, Germany PubMed articles Google scholar articles
P Schulz-Knappe 1Protagen AG, Dortmund, Germany, Dortmund, Germany PubMed articles Google scholar articles
J Gulley 2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA PubMed articles Google scholar articles
C Heery 3Bavarian Nordic, Inc., Morrisville, NC, USA PubMed articles Google scholar articles
R Madan 2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA PubMed articles Google scholar articles
J Schlom 2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA PubMed articles Google scholar articles

Citation

Budde P, Marte J, Zucht H, et al

PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-abstract.76

Publication history

First published March 21, 2018.

Online issue publication

March 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password